Smoking-Related Health Risks Among Persons With HIV in the Strategies for Management of Antiretroviral Therapy Clinical Trial
October 19, 2010
Smoking prevalence is higher among HIV-positive persons than among the general population. In the current study, the researchers sought to determine smoking-related hazard ratios (HRs) and population-attributable risk (PAR) percentage for serious clinical events and death among HIV-positive persons.
For 5,472 HIV-positive persons enrolled from 33 countries in the Strategies for Management of Antiretroviral Therapy (SMART) clinical trial, the team evaluated the relationship between baseline smoking status, development of AIDS-related or serious non-AIDS events, and overall mortality.
American Journal of Public Health
10.2010; Vol. 100; No. 10: P. 1896-1903; Alan R. Lifson, MD, MPH; Jacqueline Neuhaus, MS; Jose Ramon Arribas, MD; Mary van den Berg-Wolf, MD; Ann M. Labriola, MD; Timothy R.H. Read, MBBS; and the INSIGHT SMART Study Group
Connecting Discovery and Delivery: The Need for More Evidence on Effective Smoking Cessation Strategies for People Living With HIV/AIDS
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)